Mr. Robert Taub is a Co-Founder and serves as Chairman at Nyxoah. He serves as Board Member at Archimedicx. He serves as Board Member at NeuroDerm. He founded Recoly in 1992. Prior to establishing Recoly, Mr. Taub was the co-founder of Octapharma, a Swiss plasma fractionation and pharmaceutical company, which successfully introduced innovative plasma derivative products to the market. Mr. Taub is also the founder of Omrix Biopharmaceuticals, where he served as president, chief executive officer and a member of the board of directors until December 2008 when Omrix was acquired by Johnson and Johnson following its IPO on NASDAQ in April 2006. Prior to Octapharma, Mr. Taub held various general management and sales and marketing positions with Armour Pharmaceutical, Revlon Health Care Group, Baxter Travenol Laboratories, Inc., and Monsanto Company. He has a BA in languages from the University of Antwerp and an MBA from INSEAD in Fontainebleau, France.